The Russian Direct Funding Fund didn’t say when manufacturing would start.
Moscow: Indian biotech agency Panacea Biotec Ltd has agreed to supply 100 million doses of Russia’s Sputnik V COVID-19 vaccine yearly, the Russian Direct Funding Fund (RDIF), which markets the shot internationally, stated on Monday.
RDIF didn’t say when manufacturing would start.
(Aside from the headline, this story has not been edited by NDTV workers and is printed from a syndicated feed.)
